MARKET

EVLO

EVLO

Evelo Biosciences
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.180
-0.315
-7.01%
After Hours: 4.180 0 0.00% 16:00 12/06 EST
OPEN
4.600
PREV CLOSE
4.495
HIGH
4.605
LOW
4.160
VOLUME
43.64K
TURNOVER
--
52 WEEK HIGH
15.89
52 WEEK LOW
4.160
MARKET CAP
133.22M
P/E (TTM)
-1.7105
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of EVLO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

EVLO News

  • Evelo Biosciences Appoints Juan Andres to Board of Directors
  • GlobeNewswire.2d ago
  • The Daily Biotech Pulse: Roche's Tecentriq Snags FDA Nod For Lung Cancer, Rapt Out-Licenses Cancer Drug
  • Benzinga.3d ago
  • The Daily Biotech Pulse: Astellas To Buy Audentes For $3B, Applied Genetics Chief Medical Officer Quits, Axsome Aces Midstage Trial
  • Benzinga.4d ago
  • The Daily Biotech Pulse: Tonix Says No Surprises In FDA Meeting Minutes, Aravive Offering, FDA Nod For Qiagen
  • Benzinga.11/27 12:26

More

Industry

Biotechnology & Medical Research
+0.66%
Pharmaceuticals & Medical Research
+0.49%

Hot Stocks

Name
Price
%Change

About EVLO

Evelo Biosciences, Inc. is engaged in developing therapies designed to act on gut-body network. The Company develops monoclonal microbes that are orally-delivered compositions of specific strains of naturally occurring microbes derived from a single clone. Its principal product candidates include EDP1066, EDP1815, and EDP1503 that are in the pre-clinical development stage. EDP1066 and EDP1815 are monoclonal microbial product candidates that are developed to treat inflammatory diseases that include psoriasis, atopic dermatitis, rheumatoid arthritis, and ulcerative colitis. EDP1503 is the Company's product candidate developed under oncology portfolio to treat diseases, such as colorectal cancer, renal cell carcinoma, and melanoma among others.
More

Webull offers Evelo Biosciences Inc (EVLO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.